Matches in Wikidata for { <http://www.wikidata.org/entity/Q74284665> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q74284665 description "clinical trial" @default.
- Q74284665 description "ensayu clínicu" @default.
- Q74284665 description "klinisch onderzoek" @default.
- Q74284665 description "клінічне випробування" @default.
- Q74284665 name "Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)" @default.
- Q74284665 name "Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)" @default.
- Q74284665 type Item @default.
- Q74284665 label "Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)" @default.
- Q74284665 label "Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)" @default.
- Q74284665 prefLabel "Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)" @default.
- Q74284665 prefLabel "Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)" @default.
- Q74284665 P1132 Q74284665-02631285-200D-488B-99CA-0FB4ACA8EE70 @default.
- Q74284665 P1476 Q74284665-5CE7F141-E015-4C9F-B717-EA3637CAAE81 @default.
- Q74284665 P17 Q74284665-5402E7CA-775A-4DD5-A7AD-D73EF6FBDE2E @default.
- Q74284665 P2899 Q74284665-F5CF963A-41BF-4093-8760-D49E1F884919 @default.
- Q74284665 P3098 Q74284665-3E243216-8B74-4DAF-A100-D97B1B7A8952 @default.
- Q74284665 P31 Q74284665-186C4C0A-7685-4B1A-AAA8-A6DD1D0806C2 @default.
- Q74284665 P580 Q74284665-E65BB4B4-24F4-4E3D-9E58-B73BFB348CED @default.
- Q74284665 P582 Q74284665-D23D5A0B-5D9A-489C-9F44-F567942C042E @default.
- Q74284665 P6099 Q74284665-6577CE54-9230-4C30-9544-59FF386864A5 @default.
- Q74284665 P6099 Q74284665-AB2174FC-2BE8-4AAD-AA1B-CCD2BF3EE870 @default.
- Q74284665 P8363 Q74284665-01AFA408-1916-4EEE-BA2C-EEEA1C8CAA28 @default.
- Q74284665 P1132 "+850" @default.
- Q74284665 P1476 "Phase 2/3 Trial to Evaluate Margetuximab in Combination With INCMGA00012 and Chemotherapy or MGD013 and Chemotherapy in Patients With Metastatic or Locally Advanced, Treatment-naïve, HER2-Positive Gastric or Gastroesophageal Junction Cancer" @default.
- Q74284665 P17 Q30 @default.
- Q74284665 P2899 "+18" @default.
- Q74284665 P3098 "NCT04082364" @default.
- Q74284665 P31 Q30612 @default.
- Q74284665 P580 "2019-09-30T00:00:00Z" @default.
- Q74284665 P582 "2024-05-01T00:00:00Z" @default.
- Q74284665 P6099 Q42824440 @default.
- Q74284665 P6099 Q42824827 @default.
- Q74284665 P8363 Q78089383 @default.